Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-21-032407
Filing Date
2021-02-08
Accepted
2021-02-08 16:34:53
Documents
15

Document Format Files

Seq Description Document Type Size
1 424B4 d50231d424b4.htm 424B4 2440919
2 GRAPHIC g50231g01a01.jpg GRAPHIC 52500
3 GRAPHIC g50231g01a02.jpg GRAPHIC 55700
4 GRAPHIC g50231g01p31.jpg GRAPHIC 50574
5 GRAPHIC g50231g01p33.jpg GRAPHIC 101703
6 GRAPHIC g50231g01p35.jpg GRAPHIC 61324
7 GRAPHIC g50231g01p36.jpg GRAPHIC 93410
8 GRAPHIC g50231g02b02.jpg GRAPHIC 83316
9 GRAPHIC g50231g05b95.jpg GRAPHIC 52083
10 GRAPHIC g50231g48s11.jpg GRAPHIC 72001
11 GRAPHIC g50231g51v24.jpg GRAPHIC 152075
12 GRAPHIC g50231g57q58.jpg GRAPHIC 67249
13 GRAPHIC g50231g59a58.jpg GRAPHIC 74107
14 GRAPHIC g50231g61e85.jpg GRAPHIC 49685
15 GRAPHIC g50231g91z22.jpg GRAPHIC 83739
  Complete submission text file 0001193125-21-032407.txt   3840429
Mailing Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000
Business Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN P7 00000 31 (0)71 203 6410
Pharvaris N.V. (Filer) CIK: 0001830487 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-252157 | Film No.: 21601894
SIC: 2834 Pharmaceutical Preparations